S. 5026 explained · 119th Congress · Pending in Congress
Childhood Diabetes Reduction Act of 2026
Cosponsors: none · per Congress.gov, 2026-10-14
Introduced: 2026-07-16
Latest action (2026-07-28): Placed on Senate Legislative Calendar under General Orders. Calendar No. 531.
What S. 5026 does, in plain terms
Childhood Diabetes Reduction Act of 2026 This bill requires health warnings on labels and in advertisements for food and beverages that are sweetened, processed, or contain a high level of certain nutrients of concern, and it prohibits specifically advertising such products to children. It also expands research and outreach on proper nutrition. The bill requires various Food and Drug Administration (FDA) warnings on labels for (1) sugar-sweetened beverages, (2) food and beverages with non-sugar sweeteners, and (3) ultra-processed food and beverages. These warnings must contain specified information regarding the risks of developing certain health conditions (e.g., diabetes); warnings for sweetened food and beverages must specifically say that these products are not recommended for children. If a food or beverage contains a nutrient of concern (e.g., added sugar, saturated fat, or sodium) at a level that poses health risks, its label must indicate that the product is high in the relevant nutrient. Additionally, the bill prohibits marketing or advertising these products to children under the Federal Food, Drug, and Cosmetic Act, which is primarily enforced by the FDA. Further, marketing or advertising these products to children, or without including the required warnings, is considered an unfair or deceptive trade practice that is subject to action by the Federal Trade Commission (FTC). The bill specifically restores the FTC's statutory authority to regulate advertising targeting children. (This authority was limited in 1980.) Finally, the bill expands research on nutrition science and requires a public education campaign about nutrition and exercise.
Official summary by the Congressional Research Service, via Congress.gov.
Constitution Index
“VFA Constitution grade”
Not graded yet
S. 5026 has not been graded yet. New measures with an official summary are graded daily under the published rubric.
The Framers
“Founders’ Verdict”
Confidence 0.50
Archived SI output (machine-generated)No editorial review recorded. This historical SI verdict was machine-generated by software and predates the review desk; check it against the official bill text.
Synthesis
The Childhood Diabetes Reduction Act of 2026 is constitutional only if it operates through conditional spending under the General Welfare Clause or regulates activities that substantially affect interstate commerce under the Commerce Clause, and does not commandeer state governments or exceed the enumerated powers of Congress.
The constitutionality of the Childhood Diabetes Reduction Act of 2026 hinges on the precise means it employs. If the bill proposes spending under the General Welfare Clause (Article I, Section 8, Clause 1) to fund state programs or private initiatives, it is a valid exercise of federal power, as the power to tax and spend is broad and may be applied to objects of national concern, such as public health. However, if the bill directly regulates the conduct of individuals or states (e.g., mandating dietary standards or school curricula) without a clear nexus to interstate commerce or a treaty pow…
This bill exceeds the limited and enumerated powers delegated to the federal government by the Constitution. Nowhere in Article I, Section 8 is the Congress granted authority to regulate or legislate upon matters of health, medicine, or the prevention of disease. Such powers are reserved to the several States and to the people under the Tenth Amendment. To permit the general government to act in this sphere would be to create a boundless, consolidating jurisdiction, destructive of the true principles of a federal republic.
The proposed act seeks to regulate a matter of public health—childhood diabetes reduction—which falls within the traditional police powers reserved to the several States. The Constitution grants Congress only enumerated powers, and health regulation is not among them. While the Commerce Clause (Article I, Section 8, Clause 3) might be invoked, the mere existence of a health concern does not establish a sufficient nexus to interstate commerce to justify federal intervention. To allow such a broad reading would invite an indefinite expansion of federal authority, undermining the principle of lim…
The constitutionality of the Childhood Diabetes Reduction Act of 2026 depends upon whether its provisions are directed at regulating activities that substantially affect interstate commerce and whether the means chosen are appropriate and plainly adapted to that legitimate end. Under the Commerce Clause (Article I, Section 8, Clause 3), Congress possesses plenary power over commerce among the several states, as affirmed in Gibbons v. Ogden (1824). The Necessary and Proper Clause (Article I, Section 8, Clause 18) further grants Congress the authority to employ all means which are appropriate an…
Report an error in this Founders' Verdict
What should pass
“VFA SI Solution”
No solution yet
A sourced SI draft appears here once it passes automated checks (Constitution citation, source verification, independent SI critic). How publication works.
For journalists and bloggers
“Embed this grade”
Free to use with the link back. The badge and card update when the grade changes. Embed terms →
